General information
Aeterna Zentaris GmbH
Weismüllerstrasse 50
60314 Frankfurt, Hessen
Germany
Contact person: Klaus Paulini, Chief Executive Officer
Company main phone: +49 (69) 426023228
Company main fax: +49 (69) 426023444
Website: https://www.aezsinc.com
Year founded: | 2002
|
Source of foundation: | Subsidiary |
Name of foundation source: | Aeterna Zentaris, Inc. |
Corporate description / mission:
Aeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. The development and research site is based in Germany.
State of ownership: Subsidiary
Headquarters: No
Categorization
Sector: |
- Biotechnology - Therapeutics and Diagnostics
|
Subsector: |
- Peptides
- Small molecules
- Vaccines
|
Primary therapeutic areas: |
- Endocrine, nutritional and metabolic diseases / endocrinology
|
Customer segments: |
- Hospitals
- Large biotech & big pharma
- Physicians / doctors
|
Summary Products / Services / Technologies
Number of Biotech Products
Pre-clinical: | 6 | |
Phase III: | 1 | |
On the market: | 1 | |
Description of products:
Macimorelin
AEZS-150